Maze Therapeutics, Inc. (MAZE) News
Track canonical SquawkNews coverage tagged to MAZE, Maze Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Maze Therapeutics Q2 EPS $(0.76) Misses $(0.73) Estimate
Maze Therapeutics (NASDAQ: MAZE ) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.73) by 4.11 percent. This is a 1.3 percent increase over losses of $(0.77) per share fro
EARNINGS | Aug 11, 2026, 08:36 PM UTC
L
MAZE - Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
MAZE - Maze Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
EARNINGS | Aug 11, 2026, 08:01 PM UTC